imfinzi durvalumab biggest competitor | 1.81 | 0.6 | 9935 | 37 | 17 |
imfinzi durvalumab biggest competitor in cost | 1.08 | 0.6 | 8951 | 45 | 37 |
imfinzi durvalumab biggest comparison | 1.71 | 0.3 | 7336 | 37 | 41 |
imfinzi durvalumab biggest controversy | 0.65 | 0.6 | 4370 | 38 | 6 |
imfinzi durvalumab biggest collaboration | 0.47 | 0.7 | 4598 | 40 | 6 |
imfinzi durvalumab biggest company | 0.36 | 0.9 | 3805 | 34 | 6 |
imfinzi durvalumab biggest cost | 0.33 | 0.6 | 951 | 31 | 31 |
imfinzi durvalumab biggest clinical trial | 1.96 | 0.8 | 11 | 41 | 79 |
imfinzi durvalumab biggest customer | 1.49 | 0.4 | 4909 | 35 | 41 |
imfinzi durvalumab biggest challenge | 1.33 | 0.6 | 4561 | 36 | 15 |
imfinzi durvalumab biggest commercial | 1.84 | 0.7 | 3455 | 37 | 12 |
imfinzi biggest competitor in clinical trials | 0.55 | 0.1 | 8223 | 45 | 13 |
imfinzi biggest competitor in cost | 1.82 | 0.2 | 2276 | 34 | 13 |
imfinzi biggest competitor in market share | 1.19 | 0.2 | 150 | 42 | 59 |
durvalumab imfinzi package insert | 1.02 | 0.3 | 8480 | 33 | 2 |
imfinzi biggest competitor in survival rates | 0.79 | 0.3 | 7310 | 44 | 83 |
imfinzi biggest competitor in oncology | 0.58 | 0.1 | 9492 | 38 | 66 |
imfinzi biggest competitor in side effects | 0.38 | 0.7 | 8617 | 42 | 39 |
imfinzi biggest competitor in immunotherapy | 1.48 | 0.7 | 4800 | 43 | 38 |
imfinzi durvalumab side effects | 0.99 | 0.9 | 3998 | 31 | 61 |
j code for imfinzi durvalumab | 1.62 | 0.8 | 1683 | 29 | 20 |
imfinzi biggest competitor in lung cancer | 1.95 | 0.3 | 4401 | 41 | 37 |
cpt code for durvalumab imfinzi | 1.82 | 0.7 | 2342 | 31 | 26 |